Peer Review reports
From: Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer
| Original Submission | ||
|---|---|---|
| 26 Jan 2023 | Submitted | Original manuscript |
| 11 Feb 2023 | Author responded | Author comments - Zan Shen |
| Resubmission - Version 2 | ||
| 11 Feb 2023 | Submitted | Manuscript version 2 |
| 12 Mar 2023 | Reviewed | Reviewer Report - Muhammad Khan |
| 21 Mar 2023 | Reviewed | Reviewer Report |
| 11 Apr 2023 | Author responded | Author comments - Zan Shen |
| Resubmission - Version 3 | ||
| 11 Apr 2023 | Submitted | Manuscript version 3 |
| 12 Apr 2023 | Author responded | Author comments - Zan Shen |
| Resubmission - Version 4 | ||
| 12 Apr 2023 | Submitted | Manuscript version 4 |
| 13 May 2023 | Reviewed | Reviewer Report - Muhammad Khan |
| 21 Jun 2023 | Reviewed | Reviewer Report - João Conde |
| 29 Jun 2023 | Author responded | Author comments - Zan Shen |
| Resubmission - Version 5 | ||
| 29 Jun 2023 | Submitted | Manuscript version 5 |
| 1 Jul 2023 | Author responded | Author comments - Zan Shen |
| Resubmission - Version 6 | ||
| 1 Jul 2023 | Submitted | Manuscript version 6 |
| Publishing | ||
| 13 Jul 2023 | Editorially accepted | |
| 20 Jul 2023 | Article published | 10.1186/s12885-023-11176-8 |
You can find further information about peer review here.